title: Alcoholic hepatitis: should we combine old drugs for better results?
authors.affiliation: Departments of Medicine and Nutrition, Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
authors.forename: Joaquin
authors.initials: J
authors.lastname: Cabezas
authors.affiliation: Departments of Medicine and Nutrition, Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. bataller@med.unc.edu.
authors.forename: Ramon
authors.initials: R
authors.lastname: Bataller
mesh_terms: D000111:Acetylcysteine / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019468:Disease Management; D004359:Drug Therapy, Combination / Q000379:methods; D006519:Hepatitis, Alcoholic / Q000188:drug therapy*; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use*; D012436:S-Adenosylmethionine / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D012436:S-Adenosylmethionine; D011239:Prednisolone; D000111:Acetylcysteine